Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide - A pilot study

We examined the effects of liraglutide, a glucagon-like peptide-1 analogue on appetite and plasma ghrelin in non-diabetic obese participants with subclinical binge eating (BE). Forty-four obese BE participants (mean age: 34 ± 9 years, BMI: 35.9 ± 4.2 kg/m2) were randomly assigned to intervention or...

Full description

Bibliographic Details
Published in:Obesity Research and Clinical Practice
Main Author: Robert S.A.; Rohana A.G.; Shah S.A.; Chinna K.; Wan Mohamud W.N.; Kamaruddin N.A.
Format: Letter
Language:English
Published: Elsevier Ltd 2015
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930868992&doi=10.1016%2fj.orcp.2015.03.005&partnerID=40&md5=857369c0ee9b56aed1f123e7a4d13b15

Similar Items